The multistep synthesis of two pyrazolo [3,4-f][1,2,3,5]tetrazepin-4(3H)-one derivatives, a new class of fused 1,2,3,5-tetrazepinones with potential antiproliferative activity, has been carried out. Owing to the instability of the above compounds, the last step of the synthesis was performed at -5/0 °C. The obtained tetrazepinones, when allowed to stand at r.t. for 24 h, afforded quantitatively 1-phenyl-3,6-dimethylpyrazolo [3,4-d][1,2,3]triazole.
Introduction
The emergence of drug resistance in cancer treatment calls for the availability of new chemotherapeutic agents able to overcome this problem. In 1999 the F.D.A. (USA) approved the DNA-methylating agent temozolomide 1, principle active of Temodar®, for the treatment of refractory brain tumors. [1] [2] [3] Temozolomide leads to the methylation at the O 6 -position of guanosine residues in DNA. 4, 5 Unfortunately, it also induces high levels of O 6 -alkylguanine-DNA alkyltransferase (AGT), 6 a DNA repair protein that removes the guanine methyl group, 7 and as a consequence drug resistance arises. The literature reports the synthesis of some benzo-1,2,3,5-tetrazepin-4(3H)-ones which, like temozolomide, contain the N=N-N(CH 3 )CO-N atomic sequence. [8] [9] [10] Among the above tetrazepinones, compounds 2 was shown to be much more active than temozolomide when tested against a variety of alkylating agent resistant cell lines. 11, 12 Taking into account the antiproliferative activity of benzo-1,2,3,5-tetrazepinones and considering that the literature provides very few examples of derivatives containing the tetrazepinone ring fused to a heterocyclic nucleus, we thought it would be of interest to synthesize new derivatives containing the tetrazepinone ring fused to a heterocyclic one, and thereby to gain more insight into the structure-activity relationship of fused 1,2,3,5-tetrazepinones. Here we describe the attempts for synthesis of pyrazolo [3,4- 
Results and Discussion
The known starting material 3, prepared according to literature procedures 13 from 3-methyl-1-phenyl-1H-pyrazol-5-amine by a four steps route, was treated with methyl isocyanate in order to obtain the urea derivative 7a (see scheme 1). However, the structural isomer 4 was instead obtained, thus showing that the pyrazole 4-amino group is more nucleophilic than the 5-methylamino one. At this point the 4-amino group of 3 was protected with a benzyloxycarbonyl group, by treatment with benzyl chloroformate, giving 5 which was then reacted with methyl and ethyl isocyanates. The obtained ureas 6a,b were deprotected by treatment with hydrogen and 10% Pd-C to give the desired derivatives 7a,b which, in turn, were diazotized at 0°C with nitrous acid. The diazotization solution of 7a was adjusted to pH 8 and extracted at r.t. to give a mixture from which a product was separated by column chromatography. We assigned to this compound the structure of the known 1-phenyl -3,6-dimethylpyrazolo[3,4-d]triazole 9 13 on the basis of elemental and spectroscopical data, and realized that compound 10a lost methyl isocyanate during the work-up. In order to avoid the decomposition of the desired tetrazepinones 10a,b, the procedure was modified, performing pH adjustment, extraction and evaporation of the extracts at the temperature of -5/0°C. 1 H-NMR spectra of extracts registered at 0°C showed that 10a and 10b are the unique reaction products formed from 7a and 7b respectively. Ring closure was demonstrated by the absence in the NMR spectra of the NH signal of the urea moiety of compounds 7a,b. Both NMR solutions, containing 10a and 10b, were allowed to stand at r.t. for 24 h and 1 H-NMR spectra were again registered. These spectra showed the identical signals observed in the NMR spectrum of the pyrazolo[3,4-d]triazole derivative 9. The presence of this compound in the solutions was confirmed by TLC, mp and MS measurements. Moreover, each of the above spectra showed signal(s) that we assigned to methyl and ethyl isocyanate respectively ( see experimental). When we added little amounts of the above alkyl isocyanates into the respective NMR solutions and spectra were registered again, it was observed the increase of the intensity of signal(s) previously assigned to isocyanates. These data demonstrated that methyl and ethyl isocyanate were eliminated from tetrazepinones 10a,b respectively during the standing at r.t. of the solutions (see scheme 1). The formation of the triazole derivative 9 could be rationalized by assuming the heterolitic opening of the N 2 -N 3 bond of tetrazepinone ring, that would generate a zwitterion species which, in turn, recyclize to triazole, eliminating an alkyl isocyanate molecule 8 (see scheme 2). Owing to their inherent instability, compounds 10a,b did not give satisfactory elemental analysis data. Moreover, they could not be tested in vitro to evaluate their possible antiproliferative activity. 
Experimental Section
General Procedures. All melting points were determined on a Büchi 530 capillary melting point apparatus and are uncorrected; IR spectra were recorded with a Perkin Elmer Spectrum RXI FT-IR System spectrophotometer as solid in KBr disc or nujol mull supported on NaCl disks; 1 H-NMR spectra were obtained using a Bruker AC-E 250 MHz spectrometer (tetramethylsilane as an internal standard); Mass spectra to 70 eV were obtained using an 
General procedure for benzyl (3-methyl-5-{[(alkylamino)carbonyl](methyl)amino}-1-phenyl-1H-pyrazol-4-yl)carbamates (6a,b).
To a solution of compound 5 (2 mmol) in anhydrous CHCl 3 (20 ml), methylisocyanate (1.3 ml, 20 mmol) or ethylisocyanate (2.4 ml, 30 mmol) was added, and the mixture was refluxed for 15 h to obtain compound 6a or 40 h for compound 6b. The solutions were concentrated under reduced pressure and the oily residues were crystallized. methylureas (7a,b) . To a solution of compound 6a,b (0.76 mmol) in methanol (35 ml) 10% Pd-C as a catalyst (30 mg) was added. The mixture was left under hydrogenation in a Parr apparatus at 50 psi for 20 h. After this time the suspension was filtered, and the filtrate was concentrated under reduced pressure to give an oily residue which was crystallized. 13 To a magnetically stirred cold solution (ice bath 0°C) of compound 7a (0.8 mmol) in 2N aqueous hydrochloric acid (2.5 ml), a solution of 20% aqueous sodium nitrite (0.28 ml) was added dropwise. Stirring was continued for 1 h at 0°C and after this time the reaction mixture was extracted with dichloromethane (3 x 5 ml). The water phase was treated with a saturated solution of NaHCO 3 until pH 8 and then the reaction mixture was extracted with dichloromethane (5 x 7 ml), and the combined extracts were dried (Na 2 SO 4 ) and concentrated under reduced pressure. ones (10a,b) . To a magnetically stirred cold solution (-5°C) of compound 7a,b (0.8 mmol) in 2N aqueous hydrochloric acid (2.5 ml) a solution of 20% aqueous sodium nitrite (0.28 ml) was added dropwise, keeping the temperature at -5/0°C. Stirring was continued at the above temperature for 1 h after which the reaction mixture was extracted with cold dichloromethane (-5°C) (3 x 5 ml). The water phase was treated at -5/0°C with a saturated solution of NaHCO 3 until pH 8 and then was extracted with cold dichloromethane (-5°C) (5 x 7 ml). The combined extracts were dried (Na 2 SO 4 ) and the solvent was evaporated under reduced pressure (rotary vacuum pump) at 0°C to give a practically pure clear oil. 13 The NMR solutions of tetrazepinones 10a,b were allowed to stand at r.t.
for 24 h. After this time 1 H-NMR spectra were registered. Both the spectra showed the signals (δ) for the triazole derivative 9: 2.57 (3H, s, CH 3 ); 4.14 (3H, s, CH 3 ). Moreover, they showed the signal(s) (δ) for the eliminated alkyl isocyanates 15 : (from 10a): 3.02 (3H, s, CH 3 ); (from 10b): 1.28 (3H, t, CH 3 ), 3.33 (2H, q, CH 2 ). When a little amount of alkyl isocyanate was added in the respective NMR solution and the 1 H-NMR spectra were registered again, the isocyanates signal(s) were intensified. At this point each of the NMR solutions was evaporated under vacuum and the solid residue obtained resulted be identical to 9 (TLC, mp, MS).
